With $60M in gifts, NYU Langone to create Mignone Women’s Health Collaborative and treat women at every life stage

Alec Kimmelman announced as next CEO and Dean of NYU Langone Health

Alec C. Kimmelman was named CEO and dean of NYU Grossman School of Medicine.

April 04, 2025

Partial gland removal for prostate cancer patients may avoid recurrence, study shows

A five-year study on subjects who had only the cancerous portion of their prostate glands destroyed shows that the procedure averted cancer recurrence in most patients while preserving urinary and sexual function.

March 07, 2025

Vol.51 No.09

Clinical Roundup

Cancer cells can cooperate to survive challenging conditions, NYU scientists find

A study from New York University researchers found that cancer cells work together to source nutrients from their environment—a cooperative process that was previously overlooked by scientists but may be a promising target for treating cancer. The study was published in Nature.

February 21, 2025

Vol.51 No.07

Clinical Roundup

Psychedelic drug therapy may address mental health concerns in people with cancer and addiction

One or two doses of psilocybin, a compound found in psychedelic mushrooms, may improve the mental health of cancer patients when accompanied by psychotherapy, a new report suggests. A second new study found that treatment with psilocybin resulted in lasting, positive personality changes in patients with alcohol use disorder.

January 10, 2025

Vol.51 No.01

Clinical Roundup

Hair growth drug safe at low doses for breast cancer patients, retrospective cohort study shows

A retrospective cohort study in women with breast cancer suggests that low oral doses of minoxidil taken during or after cancer treatment appear to regrow hair in most patients without causing any serious heart-related side effects that require additional therapies or hospitalization.

January 10, 2025

Vol.51 No.01

Clinical Roundup

Hair growth drug safe at low doses for breast cancer patients

A study in women with breast cancer suggests that low oral doses of minoxidil, taken during or after cancer treatment, appear to regrow hair in most patients and without causing any serious heart-related side effects that require additional therapies or hospitalization.

December 13, 2024

Vol.50 No.46

With $60M in gifts, NYU Langone to create Mignone Women’s Health Collaborative and treat women at every life stage

YOU MAY BE INTERESTED IN

Alec Kimmelman announced as next CEO and Dean of NYU Langone Health

Partial gland removal for prostate cancer patients may avoid recurrence, study shows

Cancer cells can cooperate to survive challenging conditions, NYU scientists find

Psychedelic drug therapy may address mental health concerns in people with cancer and addiction

Hair growth drug safe at low doses for breast cancer patients, retrospective cohort study shows

Hair growth drug safe at low doses for breast cancer patients

Renew today!

Subscriber content

Never miss an issue!

Login